Cholecystokinin Mediates Progression and Metastasis of Pancreatic Cancer Associated with Dietary Fat

[1]  L. Eusebi,et al.  Mechanisms of obesity-induced gastrointestinal neoplasia. , 2014, Gastroenterology.

[2]  Jill P. Smith,et al.  Cholecystokinin and pancreatic cancer: the chicken or the egg? , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[3]  C. Roland,et al.  A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. , 2013, Gastroenterology.

[4]  G. Baldwin,et al.  Comparison of Two Syngeneic Orthotopic Murine Models of Pancreatic Adenocarcinoma , 2013, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[5]  M. McArthur,et al.  Dietary Energy Balance Modulation of Kras- and Ink4a/Arf+/−-Driven Pancreatic Cancer: The Role of Insulin-like Growth Factor-I , 2013, Cancer Prevention Research.

[6]  Gang Li,et al.  High-Fat, High-Calorie Diet Promotes Early Pancreatic Neoplasia in the Conditional KrasG12D Mouse Model , 2013, Cancer Prevention Research.

[7]  Dhiraj Yadav,et al.  The epidemiology of pancreatitis and pancreatic cancer. , 2013, Gastroenterology.

[8]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[9]  K. Lillemoe,et al.  Obesity, But Not High-Fat Diet, Promotes Murine Pancreatic Cancer Growth , 2012, Journal of Gastrointestinal Surgery.

[10]  G. Dockray.  Cholecystokinin , 2012, Current opinion in endocrinology, diabetes, and obesity.

[11]  P. Bracci.  Obesity and pancreatic cancer: Overview of epidemiologic evidence and biologic mechanisms , 2012, Molecular carcinogenesis.

[12]  Joshua I. Suhonen,et al.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival. , 2010, Endocrinology.

[13]  C. Dive,et al.  Biological mechanisms linking obesity and cancer risk: new perspectives. , 2010, Annual review of medicine.

[14]  H. Pitt,et al.  Obesity potentiates the growth and dissemination of pancreatic cancer. , 2009, Surgery.

[15]  J. Permert,et al.  Increased lipid metabolism and cell turnover of MiaPaCa2 cells induced by high-fat diet in an orthotopic system. , 2009, Metabolism: clinical and experimental.

[16]  Christopher O. McGovern,et al.  Growth of Human Pancreatic Cancer Is Inhibited by Down-Regulation of Gastrin Gene Expression , 2009, Pancreas.

[17]  Jeffrey S. Morris,et al.  Body Mass Index and Risk , Age of Onset , and Survival in Patients With Pancreatic Cancer , 2009 .

[18]  M. Korc,et al.  Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. , 2009, Biochemical and biophysical research communications.

[19]  S. Watson,et al.  Role of gastrin peptides in carcinogenesis. , 2007, Cancer letters.

[20]  Jeffrey A. Johnson,et al.  Prospective Study of Hyperglycemia and Cancer Risk , 2007, Diabetes Care.

[21]  R. Jensen,et al.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. , 2007, Current topics in medicinal chemistry.

[22]  J. Alonso,et al.  Cholecystokinin Down-Regulation by RNA Interference Impairs Ewing Tumor Growth , 2007, Clinical Cancer Research.

[23]  M. Barbacid,et al.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.

[24]  D. Cummings,et al.  Gastrointestinal regulation of food intake. , 2007, The Journal of clinical investigation.

[25]  P. Sucharda,et al.  Angiogenic factors are elevated in overweight and obese individuals , 2005, International Journal of Obesity.

[26]  M. Shibuya,et al.  The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. , 2005, Clinical science.

[27]  L. Ellis,et al.  Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines , 2005, Cancer.

[28]  D. Cheresh,et al.  Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis , 2004, The Journal of cell biology.

[29]  D. Albanes,et al.  Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  M. Korc,et al.  Pathways for aberrant angiogenesis in pancreatic cancer , 2003, Molecular Cancer.

[31]  K. Shiratori,et al.  Clinical Evaluation of Oral Administration of a Cholecystokinin-A Receptor Antagonist (Loxiglumide) to Patients with Acute, Painful Attacks of Chronic Pancreatitis: A Multicenter Dose–Response Study in Japan , 2002, Pancreas.

[32]  T. Fukuda,et al.  High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma , 2000, Cancer.

[33]  Y. Taché,et al.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Waldman,et al.  Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. , 1997, The Journal of clinical investigation.

[35]  J. Rodin,et al.  Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. , 1995, Metabolism: clinical and experimental.

[36]  J. P. Smith,et al.  Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. , 1993, The American journal of physiology.

[37]  Jill P. Smith,et al.  CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium , 1991, Regulatory Peptides.

[38]  Jill P. Smith,et al.  Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990 , 1990, Digestive Diseases and Sciences.

[39]  Jill P. Smith,et al.  Effects of a high-fat diet and L364,718 on growth of human pancreas cancer , 1990, Digestive Diseases and Sciences.

[40]  L. D. Lewis,et al.  Regulation of cholecystokinin secretion by food, hormones, and neural pathways in the rat. , 1990, The American journal of physiology.

[41]  D. Brutsaert,et al.  Mechanics of K(+)-induced isotonic and isometric contractions in isolated canine coronary microarteries. , 1990, The American journal of physiology.

[42]  G. Adler,et al.  Time Course and Cellular Source of Pancreatic Regeneration Following Acute Pancreatitis in the Rat , 1986, Pancreas.

[43]  D. Carter,et al.  Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model. , 1985, British Journal of Cancer.

[44]  F. Schabel,et al.  Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. , 1984, Cancer research.

[45]  J. Morisset,et al.  Cell site and time course of DNA synthesis in pancreas after caerulein and secretin. , 1983, The American journal of physiology.

[46]  J. Elashoff,et al.  Interaction of caerulein and secretin on pancreatic size and composition in rat. , 1978, The American journal of physiology.

[47]  P. D. Webster,et al.  Hormonal control of pancreatic growth. , 1973, The Journal of clinical investigation.

[48]  P. Fitzgerald,et al.  Pancreatic acinar cell regeneration. IV. Regeneration after resection. , 1968, The American journal of pathology.

[49]  P. Fitzgerald,et al.  Pancreatic Acinar Cell Regeneration , 1966, Nature.

[50]  P. Pisani.  Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. , 2008, Archives of physiology and biochemistry.

[51]  L. Ellis,et al.  Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. , 2006, Cancer research.

[52]  J. P. Smith,et al.  Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. , 1994, The American journal of physiology.